Raymond James & Associates’s Dillards DDS Stock Holding History
Bought
Maintained
Sold
Other funds holding DDS
BPA
Raymond James & Associates's DDS Position: Q3 2024 in Review
Raymond James & Associates reduced its Dillards (DDS) stake by 3% in Q3 2024, selling an estimated $12.2K and leaving 1,036 shares worth $398K. The position accounts for ﹤0.01% of the portfolio, ranked #3239.
Raymond James & Associates first reported a position in DDS in Q3 2019 and has held it in 15 quarters since. The position peaked at $1.39M in Q1 2023. 215 funds tracked by Wall St. Rank hold DDS as of Q3 2024.
- Raymond James & Associates held 1,036 shares of Dillards worth $398K as of Q3 2024.
- Raymond James & Associates sold 32 Dillards shares in Q3 2024, an estimated $12.2K.
- Dillards made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3239 holding.
- Raymond James & Associates first reported a position in Dillards in Q3 2019 and has held it in 15 quarters since.
- Raymond James & Associates's Dillards position peaked at $1.39M in Q1 2023.
- 215 funds tracked by Wall St. Rank held Dillards as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.